| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0006 |